Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Change in Account Payables (2021 - 2025)

Biote has reported Change in Account Payables over the past 5 years, most recently at $2.5 million for Q4 2025.

  • Quarterly results put Change in Account Payables at $2.5 million for Q4 2025, up 77.61% from a year ago — trailing twelve months through Dec 2025 was $1.0 million (down 34.43% YoY), and the annual figure for FY2025 was $1.0 million, down 34.43%.
  • Change in Account Payables for Q4 2025 was $2.5 million at Biote, up from $496000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for BTMD hit a ceiling of $2.5 million in Q4 2025 and a floor of -$4.1 million in Q4 2022.
  • Median Change in Account Payables over the past 5 years was $582500.0 (2022), compared with a mean of $220700.0.
  • Biggest five-year swings in Change in Account Payables: surged 373603.04% in 2022 and later tumbled 2173.39% in 2025.
  • Biote's Change in Account Payables stood at -$321000.0 in 2021, then crashed by 1164.8% to -$4.1 million in 2022, then soared by 56.97% to -$1.7 million in 2023, then soared by 179.51% to $1.4 million in 2024, then soared by 77.61% to $2.5 million in 2025.
  • The last three reported values for Change in Account Payables were $2.5 million (Q4 2025), $496000.0 (Q3 2025), and $528000.0 (Q2 2025) per Business Quant data.